RACHEL BARTOLOMEI: Open Payments
NPI 1861880445 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 48 payments from 15 companies in 2025. Trend: 2023 $690 · 2024 $989 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $154 |
| Madrigal Pharmaceuticals | 3 | $93 |
| Janssen Biotech, Inc. | 5 | $83 |
| GENZYME CORPORATION | 2 | $63 |
| Ardelyx, Inc. | 3 | $60 |
| PFIZER INC. | 3 | $59 |
| Lilly USA, LLC | 2 | $43 |
| Organon LLC | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
Products named: ENTYVIO, REZDIFFRA, LINZESS, DUPIXENT, TREMFYA, IBSRELA, CREON, OMVOH.
Industry payments across GA — which companies pay providers there.
